Skip to content

RxSight, Inc. RXST Inventory write-downs

Inventory write-downs at other companies

Glaukos logo
GlaukosGKOS
$661.25K-40.5%

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Reported directly by RxSight, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s inventory write-downs?
RxSight, Inc. (RXST) reported inventory write-downs of $60K in Q1 2026.
How has RxSight, Inc.'s inventory write-downs changed year-over-year?
RxSight, Inc.'s inventory write-downs increased by 93.5% year-over-year, from $31K to $60K.
What is the long-term trend for RxSight, Inc.'s inventory write-downs?
Over 4 years (2021 to 2025), RxSight, Inc.'s inventory write-downs has grown at a -4.9% compound annual growth rate (CAGR), from $2.37M to $1.93M.
What does inventory write-downs mean?
This represents the non-cash expense recorded when the carrying value of inventory is reduced because it is deemed obsolete, damaged, or worth less than its original cost. Frequent or large write-downs can signal issues with inventory management, product demand, or supply chain efficiency. It provides insight into the quality of the company's current assets and potential future margin pressures.